@article{980974b5c6014dfba6c3b53f115752da,
title = "Predicting early symptomatic osteoarthritis in the human knee using machine learning classification of magnetic resonance images from the osteoarthritis initiative",
abstract = "The purpose of this study is to evaluate the ability of a machine learning algorithm to classify in vivo magnetic resonance images (MRI) of human articular cartilage for development of osteoarthritis (OA). Sixty-eight subjects were selected from the osteoarthritis initiative (OAI) control and incidence cohorts. Progression to clinical OA was defined by the development of symptoms as quantified by the Western Ontario and McMaster Universities Arthritis (WOMAC) questionnaire 3 years after baseline evaluation. Multi-slice T2-weighted knee images, obtained through the OAI, of these subjects were registered using a nonlinear image registration algorithm. T2 maps of cartilage from the central weight bearing slices of the medial femoral condyle were derived from the registered images using the multiple available echo times and were classified for “progression to symptomatic OA” using the machine learning tool, weighted neighbor distance using compound hierarchy of algorithms representing morphology (WND-CHRM). WND-CHRM classified the isolated T2 maps for the progression to symptomatic OA with 75% accuracy. Clinical significance: Machine learning algorithms applied to T2 maps have the potential to provide important prognostic information for the development of OA.",
keywords = "MRI, classification, osteoarthritis, pattern recognition, registration, segmentation",
author = "Ashinsky, {Beth G.} and Mustapha Bouhrara and Coletta, {Christopher E.} and Benoit Lehallier and Urish, {Kenneth L.} and Lin, {Ping Chang} and Goldberg, {Ilya G.} and Spencer, {Richard G.}",
note = "Funding Information: This work was supported in part by the Intramural Research Program of the NIH, National Institute on Aging. KU acknowledges support through NIH KL2 TR000146. The OAI is a public-private partnership comprised of five contracts (N01-AR-2-2258; N01-AR-2-2259; N01-AR-2-2260; N01-AR-2-2261; N01-AR-2-2262) funded by the National Institutes of Health, a branch of the Department of Health and Human Services, and conducted by the OAI Study Investigators. Private funding partners include Merck Research Laboratories; Novartis Pharmaceuticals Corporation; GlaxoSmithKline; and Pfizer, Inc. Private sector funding for the OAI is managed by the Foundation for the National Institutes of Health. This manuscript was prepared using an OAI public use data set and does not necessarily reflect the opinions or views of the OAI investigators, the NIH, or the private funding partners. Funding Information: This work was supported in part by the Intramural Research Program of the NIH, National Institute on Aging. KU acknowledges support through NIH KL2 TR000146. The OAI is a public-private partnership comprised of five contracts (N01-AR-2-2258; N01-AR-2-2259; N01-AR-2-2260; N01-AR-2-2261; N01-AR-2-2262) funded by the National Institutes of Health, a branch of the Department of Health and Human Services, and conducted by the OAI Study Investigators. Private funding partners include Merck Research Laboratories; Novartis Pharmaceuticals Corporation; GlaxoSmithK-line; and Pfizer, Inc. Private sector funding for the OAI is managed by the Foundation for the National Institutes of Health. This manuscript was prepared using an OAI public use data set and does not necessarily reflect the opinions or views of the OAI investigators, the NIH, or the private funding partners. Publisher Copyright: {\textcopyright} 2017 Orthopaedic Research Society. Published by Wiley Periodicals, Inc.",
year = "2017",
month = oct,
doi = "10.1002/jor.23519",
language = "English (US)",
volume = "35",
pages = "2243--2250",
journal = "Journal of Orthopaedic Research",
issn = "0736-0266",
publisher = "John Wiley and Sons Inc.",
number = "10",
}